China’s leading coronavirus vaccine developer signed an agreement with a drugmaker in Brazil to conduct further testing of its shot’s efficacy, as the global race intensifies to come up with the first viable candidate to prevent Covid-19.Beijing-based Sinovac Biotech Ltd. is teaming up with Instituto Butantan to conduct the final phase of a three-part human testing of a vaccine it developed against the novel coronavirus, the company said in a statement. A Sinovac spokesman said it will need to obtain regulatory approval in Brazil before conducting the trial.
Once approved, Sinovac and Instituto Butantan will kick off the trial involving 9,000 people in July. The Brazilian drugmaker will get to license the Chinese vaccine and make it available in the South American country, Sinovac said.
Via Hindustan Times